FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Mary Cotter

Research Profile

Disorders

Physiology

Living Beings

Anatomy

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
Matthew R Nangle; Mary A Cotter; Norman E Cameron
Poly(ADP-ribose) polymerase inhibition reverses nitrergic neurovascular dysfunctions in penile erectile tissue from streptozotocin-diabetic mice.
Mary A Cotter; T Michael Gibson; Matthew R Nangle; Norman E Cameron
Effects of interleukin-6 treatment on neurovascular function, nerve perfusion and vascular endothelium in diabetic rats.
Norman E Cameron; Mary A Cotter
Pro-inflammatory mechanisms in diabetic neuropathy: focus on the nuclear factor kappa B pathway.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Mary Cotter (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Matthew R Nangle; Mary A Cotter; Norman E Cameron
Poly(ADP-ribose) polymerase inhibition reverses nitrergic neurovascular dysfunctions in penile erectile tissue from streptozotocin-diabetic mice.
The journal of sexual medicine 2010;7(10):3396-403.
2010: Mary A Cotter; T Michael Gibson; Matthew R Nangle; Norman E Cameron
Effects of interleukin-6 treatment on neurovascular function, nerve perfusion and vascular endothelium in diabetic rats.
Diabetes, obesity & metabolism 2010;12(8):689-99.
2008: Norman E Cameron; Mary A Cotter
Pro-inflammatory mechanisms in diabetic neuropathy: focus on the nuclear factor kappa B pathway.
Current drug targets 2008;9(1):60-7.
2007: Norman E Cameron; Mary A Cotter
The neurocytokine, interleukin-6, corrects nerve dysfunction in experimental diabetes.
Experimental neurology 2007;207(1):23-9.
2007: Norman E Cameron; Mary A Cotter
Erectile dysfunction and diabetes mellitus: mechanistic considerations from studies in experimental models.
Current diabetes reviews 2007;3(3):149-58.
2007: Melanie E Inkster; Mary A Cotter; Norman E Cameron
Treatment with the xanthine oxidase inhibitor, allopurinol, improves nerve and vascular function in diabetic rats.
European journal of pharmacology 2007;561(1-3):63-71.
2006: T Michael Gibson; Mary A Cotter; Norman E Cameron
Effects of poly(ADP-ribose) polymerase inhibition on dysfunction of non-adrenergic non-cholinergic neurotransmission in gastric fundus in diabetic rats.
Nitric oxide : biology and chemistry / official journal of the Nitric Oxide Society 2006;15(4):344-50.
2006: Matthew R Nangle; Mary A Cotter; Norman E Cameron
Alteration of aortic function from streptozotocin-diabetic rats with Kilham's virus is associated with inducible nitric oxide synthase.
Veterinary journal (London, England : 1997) 2006;172(3):455-9.
2006: Matthew R Nangle; Mary A Cotter; Norman E Cameron
IkappaB kinase 2 inhibition corrects defective nitrergic erectile mechanisms in diabetic mouse corpus cavernosum.
Urology 2006;68(1):214-8.
2006: Matthew R Nangle; Mary A Cotter; Norman E Cameron
The calpain inhibitor, A-705253, corrects penile nitrergic nerve dysfunction in diabetic mice.
European journal of pharmacology 2006;538(1-3):148-53.
2006: Matthew R Nangle; T Michael Gibson; Mary A Cotter; Norman E Cameron
Effects of eugenol on nerve and vascular dysfunction in streptozotocin-diabetic rats.
Planta medica 2006;72(6):494-500.
2006: Matthew R Nangle; Mary A Cotter; Norman E Cameron
Correction of nitrergic neurovascular dysfunction in diabetic mouse corpus cavernosum by p38 mitogen-activated protein kinase inhibition.
International journal of impotence research 2006;18(3):258-63.
2005: Norman E Cameron; T Michael Gibson; Matthew R Nangle; Mary A Cotter
Inhibitors of advanced glycation end product formation and neurovascular dysfunction in experimental diabetes.
Annals of the New York Academy of Sciences 2005;1043():784-92.
2004: Matthew R Nangle; Mary A Cotter; Norman E Cameron
Effects of the peroxynitrite decomposition catalyst, FeTMPyP, on function of corpus cavernosum from diabetic mice.
European journal of pharmacology 2004;502(1-2):143-8.
2004: Matthew R Nangle; Mary A Cotter; Norman E Cameron
An in vitro investigation of aorta and corpus cavernosum from eNOS and nNOS gene-deficient mice.
Pflügers Archiv : European journal of physiology 2004;448(2):139-45.
2003: Matthew R Nangle; Mary A Cotter; Norman E Cameron
An in vitro study of corpus cavernosum and aorta from mice lacking the inducible nitric oxide synthase gene.
Nitric oxide : biology and chemistry / official journal of the Nitric Oxide Society 2003;9(4):194-200.
2003: Matthew R Nangle; Mary A Cotter; Norman E Cameron
Effects of rosuvastatin on nitric oxide-dependent function in aorta and corpus cavernosum of diabetic mice: relationship to cholesterol biosynthesis pathway inhibition and lipid lowering.
Diabetes 2003;52(9):2396-402.
2003: Mary A Cotter; Norman E Cameron
Effect of the NAD(P)H oxidase inhibitor, apocynin, on peripheral nerve perfusion and function in diabetic rats.
Life sciences 2003;73(14):1813-24.
2003: Matthew R Nangle; Mary A Cotter; Norman E Cameron
Protein kinase C beta inhibition and aorta and corpus cavernosum function in streptozotocin-diabetic mice.
European journal of pharmacology 2003;475(1-3):99-106.
2003: T Michael Gibson; Mary A Cotter; Norman E Cameron
Effects of alpha-lipoic acid on impaired gastric fundus innervation in diabetic rats.
Free radical biology & medicine 2003;35(2):160-8.
2003: Norman Cameron; Mary A Cotter; Melanie Inkster; Matthew R Nangle
Looking to the future: diabetic neuropathy and effects of rosuvastatin on neurovascular function in diabetes models.
Diabetes research and clinical practice 2003;61 Suppl 1():S35-9.
2003: Mary A Cotter; Karin Ekberg; John Wahren; Norman E Cameron
Effects of proinsulin C-peptide in experimental diabetic neuropathy: vascular actions and modulation by nitric oxide synthase inhibition.
Diabetes 2003;52(7):1812-7.
2003: Norman E Cameron; Mary A Cotter
The effects of 5-hydroxytryptamine 5-HT2 receptor antagonists on nerve conduction velocity and endoneurial perfusion in diabetic rats.
Naunyn-Schmiedeberg's archives of pharmacology 2003;367(6):607-14.
2002: Melanie E Inkster; Mary A Cotter; Norman E Cameron
Effects of trientine, a metal chelator, on defective endothelium-dependent relaxation in the mesenteric vasculature of diabetic rats.
Free radical research 2002;36(10):1091-9.
2002: Alison M Jack; Alan Keegan; Mary A Cotter; Norman E Cameron
Effects of diabetes and evening primrose oil treatment on responses of aorta, corpus cavernosum and mesenteric vasculature in rats.
Life sciences 2002;71(16):1863-77.
2002: Mary A Cotter; Alison M Jack; Norman E Cameron
Effects of the protein kinase C beta inhibitor LY333531 on neural and vascular function in rats with streptozotocin-induced diabetes.
Clinical science (London, England : 1979) 2002;103(3):311-21.
2002: Norman E Cameron; Mary A Cotter
Effects of protein kinase Cbeta inhibition on neurovascular dysfunction in diabetic rats: interaction with oxidative stress and essential fatty acid dysmetabolism.
Diabetes/metabolism research and reviews 2002;18(4):315-23.
2002: Heather C Ellington; Mary A Cotter; Norman E Cameron; Ruth A Ross
The effect of cannabinoids on capsaicin-evoked calcitonin gene-related peptide (CGRP) release from the isolated paw skin of diabetic and non-diabetic rats.
Neuropharmacology 2002;42(7):966-75.
2001: Norman E Cameron; Simon E M Eaton; Mary A Cotter; Solomon Tesfaye
Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy.
Diabetologia 2001;44(11):1973-88.
2001: Alan Keegan; Mary A Cotter; Norman E Cameron
Corpus cavernosum dysfunction in diabetic rats: effects of combined alpha-lipoic acid and gamma-linolenic acid treatment.
Diabetes/metabolism research and reviews 2001;17(5):380-6.
2001: Norman E Cameron; Z Tuck; L McCabe; Mary A Cotter
Effect of the hydroxyl radical scavenger, dimethylthiourea, on peripheral nerve tissue perfusion, conduction velocity and nociception in experimental diabetes.
Diabetologia 2001;44(9):1161-9.
2001: I Ford; Mary A Cotter; Norman E Cameron; M Greaves
The effects of treatment with alpha-lipoic acid or evening primrose oil on vascular hemostatic and lipid risk factors, blood flow, and peripheral nerve conduction in the streptozotocin-diabetic rat.
Metabolism: clinical and experimental 2001;50(8):868-75.
2001: Norman E Cameron; Mary A Cotter
Diabetes causes an early reduction in autonomic ganglion blood flow in rats.
Journal of diabetes and its complications 2001;15(4):198-202.
2001: Norman E Cameron; Alison M Jack; Mary A Cotter
Effect of alpha-lipoic acid on vascular responses and nociception in diabetic rats.
Free radical biology & medicine 2001;31(1):125-35.
2001: Norman E Cameron; Mary A Cotter
Effects of an extracellular metal chelator on neurovascular function in diabetic rats.
Diabetologia 2001;44(5):621-8.
2001: Mary A Cotter; D J Mirrlees; Norman E Cameron
Neurovascular interactions between aldose reductase and angiotensin-converting enzyme inhibition in diabetic rats.
European journal of pharmacology 2001;417(3):223-30.
2000: TC Hohman; Mary A Cotter; Norman E Cameron
ATP-sensitive K(+) channel effects on nerve function, Na(+), K(+) ATPase, and glutathione in diabetic rats.
European journal of pharmacology 2000;397(2-3):335-41.
2000: Alan Keegan; Alison M Jack; Mary A Cotter; Norman E Cameron
Effects of aldose reductase inhibition on responses of the corpus cavernosum and mesenteric vascular bed of diabetic rats.
Journal of cardiovascular pharmacology 2000;35(4):606-13.
2000: H Flint; Mary A Cotter; Norman E Cameron
Pentoxifylline effects on nerve conduction velocity and blood flow in diabetic rats.
International journal of experimental diabetes research 2000;1(1):49-58.
1999: Norman E Cameron; Mary A Cotter
Effects of antioxidants on nerve and vascular dysfunction in experimental diabetes.
Diabetes research and clinical practice 1999;45(2-3):137-46.
1999: Alan Keegan; Mary A Cotter; Norman E Cameron
Effects of chelator treatment on aorta and corpus cavernosum from diabetic rats.
Free radical biology & medicine 1999;27(5-6):536-43.
1999: Norman E Cameron; Mary A Cotter; Alison M Jack; MD Basso; TC Hohman
Protein kinase C effects on nerve function, perfusion, Na(+), K(+)-ATPase activity and glutathione content in diabetic rats.
Diabetologia 1999;42(9):1120-30.
1999: Alan Keegan; Mary A Cotter; Norman E Cameron
Effects of diabetes and treatment with the antioxidant alpha-lipoic acid on endothelial and neurogenic responses of corpus cavernosum in rats.
Diabetologia 1999;42(3):343-50.
1999: Alison M Jack; Norman E Cameron; Mary A Cotter
Effects of the diacylglycerol complexing agent, cremophor, on nerve-conduction velocity and perfusion in diabetic rats.
Journal of diabetes and its complications 1999;13(1):2-9.
1998: Norman E Cameron; Mary A Cotter; D H Horrobin; H J Tritschler
Effects of alpha-lipoic acid on neurovascular function in diabetic rats: interaction with essential fatty acids.
Diabetologia 1998;41(4):390-9.
1998: Mary A Cotter; Norman E Cameron
Correction of neurovascular deficits in diabetic rats by beta2-adrenoceptor agonist and alpha1-adrenoceptor antagonist treatment: interactions with the nitric oxide system.
European journal of pharmacology 1998;343(2-3):217-23.
1998: Mary A Cotter; Norman E Cameron; TC Hohman
Correction of nerve conduction and endoneurial blood flow deficits by the aldose reductase inhibitor, tolrestat, in diabetic rats.
Journal of the peripheral nervous system : JPNS 1998;3(3):217-23.
1997: Norman E Cameron; Mary A Cotter
Metabolic and vascular factors in the pathogenesis of diabetic neuropathy.
Diabetes 1997;46 Suppl 2():S31-7.
1997: Mary A Cotter; Norman E Cameron
Effects of dietary supplementation with arachidonic acid rich oils on nerve conduction and blood flow in streptozotocin-diabetic rats.
Prostaglandins, leukotrienes, and essential fatty acids 1997;56(5):337-43.
1997: Norman E Cameron; Mary A Cotter; M Basso; TC Hohman
Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats.
Diabetologia 1997;40(3):271-81.
1997: Norman E Cameron; Mary A Cotter
Neurovascular effects of L-carnitine treatment in diabetic rats.
European journal of pharmacology 1997;319(2-3):239-44.
1997: E K Maxfield; Norman E Cameron; Mary A Cotter
Effects of diabetes on reactivity of sciatic vasa nervorum in rats.
Journal of diabetes and its complications 1997;11(1):47-55.
1997: A Love; Mary A Cotter; Norman E Cameron
Effects of alpha-tocopherol on nerve conduction velocity and regeneration following a freeze lesion in immature diabetic rats.
Naunyn-Schmiedeberg's archives of pharmacology 1997;355(1):126-30.
1996: A Love; Mary A Cotter; Norman E Cameron
Nerve function and regeneration in diabetic and galactosaemic rats: antioxidant and metal chelator effects.
European journal of pharmacology 1996;314(1-2):33-9.
1996: K C Dines; Mary A Cotter; Norman E Cameron
Effectiveness of natural oils as sources of gamma-linolenic acid to correct peripheral nerve conduction velocity abnormalities in diabetic rats: modulation by thromboxane A2 inhibition.
Prostaglandins, leukotrienes, and essential fatty acids 1996;55(3):159-65.
1996: Norman E Cameron; Mary A Cotter
Comparison of the effects of ascorbyl gamma-linolenic acid and gamma-linolenic acid in the correction of neurovascular deficits in diabetic rats.
Diabetologia 1996;39(9):1047-54.
1996: Norman E Cameron; Mary A Cotter
Interaction between oxidative stress and gamma-linolenic acid in impaired neurovascular function of diabetic rats.
The American journal of physiology 1996;271(3 Pt 1):E471-6.
1996: Norman E Cameron; Mary A Cotter
Effects of a nonpeptide endothelin-1 ETA antagonist on neurovascular function in diabetic rats: interaction with the renin-angiotensin system.
The Journal of pharmacology and experimental therapeutics 1996;278(3):1262-8.
1996: Norman E Cameron; Mary A Cotter
Rapid reversal by aminoguanidine of the neurovascular effects of diabetes in rats: modulation by nitric oxide synthase inhibition.
Metabolism: clinical and experimental 1996;45(9):1147-52.
1996: A Love; Mary A Cotter; Norman E Cameron
Effects of the sulphydryl donor N-acetyl-L-cysteine on nerve conduction, perfusion, maturation and regeneration following freeze damage in diabetic rats.
European journal of clinical investigation 1996;26(8):698-706.
1996: V Archibald; Mary A Cotter; A Keegan; Norman E Cameron
Contraction and relaxation of aortas from diabetic rats: effects of chronic anti-oxidant and aminoguanidine treatments.
Naunyn-Schmiedeberg's archives of pharmacology 1996;353(5):584-91.
1996: Norman E Cameron; Mary A Cotter; TC Hohman
Interactions between essential fatty acid, prostanoid, polyol pathway and nitric oxide mechanisms in the neurovascular deficit of diabetic rats.
Diabetologia 1996;39(2):172-82.
1996: Norman E Cameron; Mary A Cotter; K C Dines; TC Hohman
Reversal of defective peripheral nerve conduction velocity, nutritive endoneurial blood flow, and oxygenation by a novel aldose reductase inhibitor, WAY-121,509, in streptozotocin-induced diabetic rats.
Journal of diabetes and its complications 1996;10(1):43-53.
1995: A Love; Mary A Cotter; Norman E Cameron
Impaired myelinated fiber regeneration following freeze-injury in rats with streptozotocin-induced diabetes: involvement of the polyol pathway.
Brain research 1995;703(1-2):105-10.
1995: Norman E Cameron; Mary A Cotter
Reversal of peripheral nerve conduction and perfusion deficits by the free radical scavenger, BM15.0639, in diabetic rats.
Naunyn-Schmiedeberg's archives of pharmacology 1995;352(6):685-90.
1995: Alan Keegan; H Walbank; Mary A Cotter; Norman E Cameron
Chronic vitamin E treatment prevents defective endothelium-dependent relaxation in diabetic rat aorta.
Diabetologia 1995;38(12):1475-8.
1995: Mary A Cotter; A Love; M J Watt; Norman E Cameron; K C Dines
Effects of natural free radical scavengers on peripheral nerve and neurovascular function in diabetic rats.
Diabetologia 1995;38(11):1285-94.
1995: Mary A Cotter; Norman E Cameron; A Keegan; K C Dines
Effects of acetyl- and proprionyl-L-carnitine on peripheral nerve function and vascular supply in experimental diabetes.
Metabolism: clinical and experimental 1995;44(9):1209-14.
1995: E K Maxfield; A Love; Mary A Cotter; Norman E Cameron
Nerve function and regeneration in diabetic rats: effects of ZD-7155, an AT1 receptor antagonist.
The American journal of physiology 1995;269(3 Pt 1):E530-7.
1995: C D Dines; Mary A Cotter; Norman E Cameron
Nerve function in galactosaemic rats: effects of evening primrose oil and doxazosin.
European journal of pharmacology 1995;281(3):303-9.
1995: Norman E Cameron; Mary A Cotter
Neurovascular dysfunction in diabetic rats. Potential contribution of autoxidation and free radicals examined using transition metal chelating agents.
The Journal of clinical investigation 1995;96(2):1159-63.
1995: Mary A Cotter; Norman E Cameron
Neuroprotective effects of carvedilol in diabetic rats: prevention of defective peripheral nerve perfusion and conduction velocity.
Naunyn-Schmiedeberg's archives of pharmacology 1995;351(6):630-5.
1995: K C Dines; Norman E Cameron; Mary A Cotter
Comparison of the effects of evening primrose oil and triglycerides containing gamma-linolenic acid on nerve conduction and blood flow in diabetic rats.
The Journal of pharmacology and experimental therapeutics 1995;273(1):49-55.
1995: Norman E Cameron; Mary A Cotter
Effects of chronic treatment with a nitric oxide donor on nerve conduction abnormalities and endoneurial blood flow in streptozotocin-diabetic rats.
European journal of clinical investigation 1995;25(1):19-24.
1994: Norman E Cameron; K C Dines; Mary A Cotter
The potential contribution of endothelin-1 to neurovascular abnormalities in streptozotocin-diabetic rats.
Diabetologia 1994;37(12):1209-15.
1994: Norman E Cameron; Mary A Cotter
Effects of evening primrose oil treatment on sciatic nerve blood flow and endoneurial oxygen tension in streptozotocin-diabetic rats.
Acta diabetologica 1994;31(4):220-5.
1994: Norman E Cameron; Mary A Cotter
The relationship of vascular changes to metabolic factors in diabetes mellitus and their role in the development of peripheral nerve complications.
Diabetes/metabolism reviews 1994;10(3):189-224.
1994: Norman E Cameron; Mary A Cotter; K C Dines; E K Maxfield; F Carey; D J Mirrlees
Aldose reductase inhibition, nerve perfusion, oxygenation and function in streptozotocin-diabetic rats: dose-response considerations and independence from a myo-inositol mechanism.
Diabetologia 1994;37(7):651-63.
1994: J A Barry; Mary A Cotter; Norman E Cameron; M C Pattullo
The effect of immobilization on the recovery of rabbit soleus muscle from tenotomy: modulation by chronic electrical stimulation.
Experimental physiology 1994;79(4):515-25.
1994: Norman E Cameron; Mary A Cotter; V Archibald; K C Dines; E K Maxfield
Anti-oxidant and pro-oxidant effects on nerve conduction velocity, endoneurial blood flow and oxygen tension in non-diabetic and streptozotocin-diabetic rats.
Diabetologia 1994;37(5):449-59.
1993: E K Maxfield; Norman E Cameron; Mary A Cotter; K C Dines
Angiotensin II receptor blockade improves nerve function, modulates nerve blood flow and stimulates endoneurial angiogenesis in streptozotocin-diabetic rats and nerve function.
Diabetologia 1993;36(12):1230-7.
1993: K C Dines; Mary A Cotter; Norman E Cameron
Contrasting effects of treatment with omega-3 and omega-6 essential fatty acids on peripheral nerve function and capillarization in streptozotocin-diabetic rats.
Diabetologia 1993;36(11):1132-8.
1993: Norman E Cameron; Mary A Cotter
Contraction and relaxation of aortas from galactosaemic rats and the effects of aldose reductase inhibition.
European journal of pharmacology 1993;243(1):47-53.
1993: Norman E Cameron; Mary A Cotter
Potential therapeutic approaches to the treatment or prevention of diabetic neuropathy: evidence from experimental studies.
Diabetic medicine : a journal of the British Diabetic Association 1993;10(7):593-605.
1993: Norman E Cameron; Mary A Cotter; K C Dines; S Robertson; D Cox
The effects of evening primrose oil on nerve function and capillarization in streptozotocin-diabetic rats: modulation by the cyclo-oxygenase inhibitor flurbiprofen.
British journal of pharmacology 1993;109(4):972-9.
1993: Norman E Cameron; Mary A Cotter; K C Dines; E K Maxfield
Pharmacological manipulation of vascular endothelium function in non-diabetic and streptozotocin-diabetic rats: effects on nerve conduction, hypoxic resistance and endoneurial capillarization.
Diabetologia 1993;36(6):516-22.
1993: Mary A Cotter; K C Dines; Norman E Cameron
Prevention and reversal of motor and sensory peripheral nerve conduction abnormalities in streptozotocin-diabetic rats by the prostacyclin analogue iloprost.
Naunyn-Schmiedeberg's archives of pharmacology 1993;347(5):534-40.
1993: Norman E Cameron; Mary A Cotter; E K Maxfield
Anti-oxidant treatment prevents the development of peripheral nerve dysfunction in streptozotocin-diabetic rats.
Diabetologia 1993;36(4):299-304.
1993: Mary A Cotter; Norman E Cameron; S Robertson; I Ewing
Polyol pathway-related skeletal muscle contractile and morphological abnormalities in diabetic rats.
Experimental physiology 1993;78(2):139-55.
1993: Norman E Cameron; Mary A Cotter; S Robertson; E K Maxfield
Nerve function in experimental diabetes in rats: effects of electrical stimulation.
The American journal of physiology 1993;264(2 Pt 1):E161-6.
1993: Norman E Cameron; Mary A Cotter; S Robertson
Rapid reversal of a motor nerve conduction deficit in streptozotocin-diabetic rats by the angiotensin converting enzyme inhibitor lisinopril.
Acta diabetologica 1993;30(1):46-8.
1992: S Robertson; Norman E Cameron; Mary A Cotter
The effect of the calcium antagonist nifedipine on peripheral nerve function in streptozotocin-diabetic rats.
Diabetologia 1992;35(12):1113-7.
1992: Norman E Cameron; Mary A Cotter
Dissociation between biochemical and functional effects of the aldose reductase inhibitor, ponalrestat, on peripheral nerve in diabetic rats.
British journal of pharmacology 1992;107(4):939-44.
1992: Norman E Cameron; Mary A Cotter
Impaired contraction and relaxation in aorta from streptozotocin-diabetic rats: role of polyol pathway.
Diabetologia 1992;35(11):1011-9.
1992: Norman E Cameron; Mary A Cotter; K Dines; A Love
Effects of aminoguanidine on peripheral nerve function and polyol pathway metabolites in streptozotocin-diabetic rats.
Diabetologia 1992;35(10):946-50.
1992: M C Pattullo; Mary A Cotter; Norman E Cameron; J A Barry
Effects of lengthened immobilization on functional and histochemical properties of rabbit tibialis anterior muscle.
Experimental physiology 1992;77(3):433-42.
1992: Norman E Cameron; Mary A Cotter; S Robertson; D Cox
Muscle and nerve dysfunction in rats with experimental galactosaemia.
Experimental physiology 1992;77(1):89-108.
1992: Norman E Cameron; Mary A Cotter; S Robertson
Angiotensin converting enzyme inhibition prevents development of muscle and nerve dysfunction and stimulates angiogenesis in streptozotocin-diabetic rats.
Diabetologia 1992;35(1):12-8.
1991: Norman E Cameron; Mary A Cotter; K Ferguson; S Robertson; M A Radcliffe
Effects of chronic alpha-adrenergic receptor blockade on peripheral nerve conduction, hypoxic resistance, polyols, Na(+)-K(+)-ATPase activity, and vascular supply in STZ-D rats.
Diabetes 1991;40(12):1652-8.
1991: Norman E Cameron; Mary A Cotter; S Robertson
Essential fatty acid diet supplementation. Effects on peripheral nerve and skeletal muscle function and capillarization in streptozocin-induced diabetic rats.
Diabetes 1991;40(5):532-9.
1991: Mary A Cotter; Norman E Cameron; J A Barry; M C Pattullo
Chronic stimulation accelerates functional recovery of immobilized soleus muscles of the rabbit.
Experimental physiology 1991;76(2):201-12.
1990: Norman E Cameron; Mary A Cotter; S Robertson
Changes in skeletal muscle contractile properties in streptozocin-induced diabetic rats and role of polyol pathway and hypoinsulinemia.
Diabetes 1990;39(4):460-5.
1989: Norman E Cameron; Mary A Cotter; S Robertson
Contractile properties of cardiac papillary muscle in streptozotocin-diabetic rats and the effects of aldose reductase inhibition.
Diabetologia 1989;32(6):365-70.